Septerna, Inc.

SEPN

CIK 0001984086 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$24M
↑+11276.4% +$24Mvs FY2024 (Q4)
Gross Profit
$24M
↑+11276.4% +$24Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
33/100
  • Profitability
    0ROIC -13.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 4.73 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.09x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +11276.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 12.2% · trend -4529.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SEPN's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$42.63
Total enterprise IV
$1.89B
Diluted shares
0.04B
Terminal PV
$1.37B (72% of total)
Year-5 FCF
$161M
YearProjected FCFDiscounted PV
+1$118M$108M
+2$128M$106M
+3$138M$104M
+4$149M$102M
+5$161M$100M
Terminal$2.20B$1.37B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$518K
investment in PP&E
Stock-based comp (TTM)
$8M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$596M
everything owned
Total liabilities
$214M
everything owed
Stockholders' equity
$382M
shareholder claim

Recent performance · 12 quarters

Revenue↑+11276.4% +$24M
$24M
Net Income↑+139.8% +$29M
$8M
Free Cash Flow↑+89.4% +$547K
$-65K
Operating Margin↑+12824.7pts
12.2%

Drill down